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With the aim of selecting LAB strains with antilisterial activity to be used as protective cultures to enhance the safety of dairy
products, the antimicrobial properties of 117 Lactococcus lactis subsp. lactis isolated from artisanal Sardinian dairy products
were evaluated, and six strains were found to produce bacteriocin-like substances. The capacity of these strains to antagonize
Listeria monocytogenes during cocultivation in skimmed milk was evaluated, showing a reduction of L. monocytogenes counts of
approximately 4 log units compared to the positive control after 24h of incubation. In order for a strain to be used as bioprotective
culture, it should be carefully evaluated for the presence of virulence factors, to determine what potential risks might be involved
in its use. None of the strains tested was found to produce biogenic amines or to possess haemolytic activity. In addition, all strains
were sensitive to clinically important antibiotics such as ampicillin, tetracycline, and vancomycin. Our results suggest that these
bac+ strains could be potentially applied in cheese manufacturing to control the growth of L. monocytogenes.
1.Introduction
In modern societies, the increasing consumer demand for
natural and additive-free products has led food industry to
research novel and alternative technologies in food preserva-
tion, with the objective to improve quality and safety of their
products.
The use of microorganisms and/or their natural metabo-
litestoinhibitthegrowthofpathogenicandspoilagebacteria
has appeared as a promising tool and is also perceived by the
consumerasalower-risk food preservation [1].Inparticular,
lactic acid bacteria (LAB) have acquired considerable rele-
vance in the food industry and in public health, since they
are widely used in fermented foods, have a long history of
safe use, and are commonly given the Generally Recognized
As Safe (GRAS) status [2]. The preservative ability of LAB
in food is attributed mainly to the production of antimi-
crobial substances, including organic acid, hydrogen per-
oxide, and bacteriocins [3, 4]. The latter are ribosomally
synthesized, biologically active peptides or proteins with an-
tagonistic activity against speciﬁc microorganisms [5, 6].
Many bacteriocin-producing LAB strains have proven eﬀec-
tive against spoilage and pathogenic microorganisms in food
products [7–9].
In the last decades, Listeria monocytogenes has become
one of the most signiﬁcant foodborne pathogens due to its
widespread occurrence and its ability to tolerate environ-
mental stresses such as low pH, low temperatures, and salt
concentration up to 10% [10, 11]. These characteristics
enable its frequent contamination of food products, particu-
larly those minimally processed and refrigerated. Foodborne
listeriosis is known to pose a serious health hazard when it
occursinnewborns,pregnantwomen,andimmunocompro-
mised subjects [12, 13].
Since dairy products have been frequently reported
as contaminated and associated with listeriosis outbreaks
[11, 14], new preservation strategies to control growth of2 Journal of Biomedicine and Biotechnology
L. monocytogenes have been developed, including the direct
application of bacteriocins as puriﬁed compound or the
inoculation with a bacteriocin-producer LAB strain under
conditions that favour production of the bacteriocin in situ
[15–17]. Nisin, produced by Lactococcus lactis, is currently
the only bacteriocin approved as preservative for utilization
as direct human food ingredient [18, 19]. The in-situ pro-
duction of a bacteriocin by potential adjuncts or starter cul-
tures in fermentation processes requires a bacteriocinogenic
strainthatiswelladaptedtotheparticularfoodenvironment
in which it will be used, that is able to grow under the
foodprocessingand/orstorageconditions,andthatproduces
bacteriocin in suﬃcient amounts to inhibit the target bac-
teria. LAB originally isolated from certain food products
would be the best choice as starter cultures for these same
products, because they would be more competitive than LAB
from other sources [20].
With the aim of selecting LAB strains with antilisterial
activitytobeusedasprotectiveculturestoenhancethesafety
ofdairyproducts,theantimicrobialpropertiesof117L.lactis
subsp. lactis isolated from artisanal Sardinian dairy products
were evaluated, and six strains were found to produce bacte-
riocin-like substances. The capacity of these strains to antag-
onize L. monocytogenes during cocultivation in skimmed
milk was also assessed. In addition, basic safety aspects of the
strains such as production of biogenic amines, haemolytic
activity, and antibiotic susceptibility were addressed. To our
knowledge, this is the ﬁrst report on the isolation of bacte-
riocin-like inhibitory substances from LAB strains isolated
from artisanal Sardinian dairy products.
2.MaterialsandMethods
2.1. Bacterial Strains and Culture Conditions. Bacteriocin
producer and indicator strains used in this study are listed
in Table 1. Lactococcus lactis subsp. lactis strains were iden-
tiﬁed on the basis of their morphological and biochemical
c h a r a c t e r i s t i c sa sp r e v i o u s l yr e p o r t e d[ 21]; the identiﬁcation
was conﬁrmed by PCR analysis using species-speciﬁc prim-
ers derived from 16S rRNA sequences, according to Pu et al.
[22]. They were maintained at −20◦C in M17 broth (Micro-
biol, Cagliari, Italy) with 15% (v/v) glycerol (Microbiol) and
subcultured twice as 1% inoculums in M17 broth at 30◦C
for 24h prior to experimental use. Listeria monocytogenes
ATCC 7644, Escherichia coli ATCC 35150, Enterococcus
faecalis ATCC 29212, Staphylococcus aureus ATCC 25923,
LactobacillusplantarumDSMZ20174,andLactobacillussakei
subsp. sakei DSMZ 20017 were used as indicators. All indi-
cator strains were stored on nutrient broth (Microbiol) plus
20% (v/v) glycerol at −20◦C except LAB strains which were
maintained in MRS broth (Microbiol) with 15% (v/v) glyc-
erol. Before use, they were subcultured twice in appropriate
medium.
2.2. Screening of Lactococcus lactis Strains for Antimicrobial
Compound Production. A total of 117 L. lactis subsp. lactis
strains, previously isolated from Sardinian dairy products
including raw ewes and goat milk, and artisanal ewes and
goat cheeses, were preliminarily screened for antimicrobial
Table 1: Bacteriocinogenic strains of Lactococcus lactis subsp. lactis
and indicator bacteria used in this study.
Species Strain Origin
Bacteriocinogenic strains
Lactococcus lactis subsp. lactis 9FS16 Ewes cheese
Lactococcus lactis subsp. lactis 16FS16 Ewes cheese
Lactococcus lactis subsp. lactis 9/20234 Raw ewes milk
Lactococcus lactis subsp. lactis 6LS5 Raw ewes milk
Lactococcus lactis subsp. lactis 3LC39 Raw goat milk
Lactococcus lactis subsp. lactis 1LC18 Raw goat milk
Indicator strains
Listeria monocytogenes 7644 ATCC
Escherichia coli 35150 ATCC
Enterococcus faecalis 29212 ATCC
Staphylococcus aureus 25923 ATCC
Lactobacillus plantarum 20174 DSMZ
Lactobacillus sakei subsp. sakei 20017 DSMZ
compound production against the indicator strains using an
agar spot method [23]. Overnight cultures of lactococci were
spotted (10μL) onto the surface of MRS agar (1.2% (w/v)
agar—0.2%(w/v)glucose)plates,whichwerethenincubated
anaerobically for 24h at 37◦C. The indicator strains were
inoculated into 7mL of soft agar medium (MRS or nutrient
broth containing 0.7% w/v agar) to a ﬁnal concentration
of approximately 107 CFU/mL. The soft media were poured
on the plates which were incubated for 24h at the optimal
growth temperature and atmosphere for the indicator
strains. Inhibition was scored positive in the presence of a
detectable clear zone around the colony of the producer
strain.
2.3. Antimicrobial Activity Assay. The lactococcal strains
exhibiting an inhibitory activity against at least three indica-
tor strains, among which are L. monocytogenes ATCC 7644
and the bacteriocin-sensitive strain L. sakei subsp. sakei
DSMZ 20017, were further tested for their antimicrobial ac-
tivity against L. monocytogenes ATCC 7644 using the well-
diﬀusion method as described by Shillinger and L¨ ucke [23]
with some modiﬁcations. Brieﬂy, 1% (v/v) aliquot of over-
night culture of the indicator strain was inoculated into
20mLofappropriatesoftagarmediumandpouredintoPetri
dishes.Aftercooling,wells(6mmdiameter)werecutintothe
agar and ﬁlled with 100μL aliquots of cell-free supernatant
of the potential producer strain collected by centrifugation
(10000×g, 15min). In order to eliminate the inhibitory
eﬀe c to fl a c t i ca c i da n d / o rH 2O2, the supernatants were ad-
justed to pH 6.5 with 5M NaOH, treated with catalase
(1mg/mL, Sigma, Milan, Italy), and then ﬁltered through a
0.45μm pore-size cellulose acetate ﬁlter (Millipore, Bedford
MA, USA) prior to use. The plates were refrigerated for 4h
to allow the radial diﬀusion of the compounds contained in
the supernatant prior to incubation for 24h at 37◦C. The
antimicrobial activity was expressed as the diameter of the
inhibition zones around the wells. The nisin-positive L. lactisJournal of Biomedicine and Biotechnology 3
subsp. lactis ATCC 11454 was used as positive control. Sterile
M17 broth was used as negative control.
Sensitivity to proteolytic enzymes of the cell-free super-
natants of bacteriocin producer strains was tested by treat-
mentwithpronaseE,proteinaseK,α-chymotrypsin, trypsin,
and papain (Sigma). All enzymes (10mg/mL in sterile dis-
tilled water) were ﬁlter sterilized and added to supernatants
at a ﬁnal concentration of 1mg/mL in phosphate buﬀer (pH
6.5). Following incubation at 37◦Cf o r2 h ,e n z y m e sw e r e
denatured by heating at 100◦C for 5min. Untreated samples
were used as controls. The residual activity of enzyme-
treated samples against L. monocytogenes ATCC 7644 was
determined by the well-diﬀusion method.
2.4. Antilisterial Activity: Coculture Tests in Skimmed Milk.
BacteriocinogenicL.lactissubsp.lactisstrainswereseparately
cocultured with L. monocytogenes ATCC 7644 in 100mL of
10% reconstituted skimmed milk (RSM; Oxoid, Basingstoke,
UK) at 30◦C for 24h. Bacteriocinogenic strains were inocu-
lated at about 5 × 106 CFU/mL, and L. monocytogenes had
a ﬁnal count of 106 CFU/mL. In each experiment, negative
control without bacteria, control inoculated with L. monocy-
togenes alone, and control inoculated with bacteriocinogenic
strain alone were included. After 0, 5, 10, and 24h, samples
were taken, serially diluted in sterile saline solution, and
plated onto M17 agar plates for the enumeration of L. lactis
and on PALCAM (Microbiol) agar plates for the enumera-
tion of L. monocytogenes. Values of pH were also monitored
by using a HI8520 pH meter (P.B.I., Milan, Italy).
2.5. Safety Assessment of Strains. The method of Bover-Cid
and Holzapfel [24]w a su s e dt os c r e e nLactococcus strains for
the production of biogenic amines. Brieﬂy, the test strains
were subcultured twice at 24h intervals in M17 broth
containing 1% of each precursor amino acid: tyrosine di-
sodium salt, L−histidine monohydrochloride, L−ornithine
monohydrochlorideandlysinemonohydrochloride(Sigma),
and 0.005% pyridoxal-5-phosphate (Sigma) as a codecar-
boxylase factor. All strains were then streaked in duplicate
on decarboxylase medium plates each containing only one of
the above-mentioned amino acids and bromocresol purple
as pH indicator and incubated for 4 days in anaerobic con-
ditionsat37◦C.Decarboxylasemediumwithoutaminoacids
wasusedascontrol.Acolourchangefrombrowntopurplein
the medium indicated an increase in pH and was considered
a positive result.
Haemolytic activity was determined by streaking the
strains on Columbia Blood (Microbiol) agar plates supple-
mented with 5% deﬁbrinated sheep blood after 48h of
incubationat37◦C.Thehaemolyticreactionwasrecordedby
observation of a clear zone of hydrolysis around the colonies
(β-haemolysis), a partial hydrolysis, and greenish zone (α-
haemolysis) or no reaction.
Antibiotic susceptibility testing was carried out by disc
diﬀusion method according to the Clinical and Laboratory
Standards Institute (CLSI) guidelines [25], but Mueller-
Hinton agar was replaced by M17 agar. The following antibi-
otics (Oxoid or BBL) were tested: ampicillin (AM; 10μg),
vancomycin (VA; 30μg) (inhibitors of cell wall synthesis),
streptomycin (S; 10μg), tetracycline (TE; 30μg), gentamicin
(GM; 10μg), kanamycin (K; 30μg ) ,e ryt h r o m y c i n( E ;1 5μg),
chloramphenicol (C; 30μg), clindamycin (CM; 2μg) (in-
hibitors of protein synthesis), ciproﬂoxacin (CIP; 5μg), and
trimethoprim/sulphamethoxazole (SXT; 25μg) (inhibitors
of nucleic acids). A suspension from fresh overnight cultures
with a density of McFarland 0.5 in buﬀered saline was plated
on M17 agar plates; then, antibiotic discs were dispensed
ontotheplates.Afterincubationat37◦Cfor24hinanaerobi-
osis, the diameters of the bacterial-free zone were measured,
and results were expressed in terms of resistance according to
the interpretative criteria issued by the CLSI [26].
3. Results and Discussion
The antagonistic eﬀect of LAB dairy strains on pathogenic
microorganisms could be used for expanding the range of
healthful dairy foods. LAB, originally isolated from raw milk
or artisanal dairy products, are probably the best candidate
for improving the microbiological safety of these foods, be-
causetheyarewelladaptedtotheconditionsofthesubstrate.
In this study a total of 117 Lactococcus lactis subsp. lactis
strains, isolated from artisanal Sardinian dairy products,
were preliminarily screened for antimicrobial compound
production against six indicator strains, including well-
recognized foodborne pathogens, by means of an agar spot
method (Figure 1). Twenty-eight strains were found to pro-
duce an inhibition zone against at least three indicators,
among which are Listeria monocytogenes ATCC 7644 and the
bacteriocin-sensitive strain Lactobacillus sakei subsp. sakei
DSMZ 20017, and were selected for further investigation.
Subsequently, the cell-free supernatants from these strains
weretreatedwithcatalase,neutralized,sterilizedbyﬁltration,
and tested by well-diﬀusion assay against L. monocytogenes
ATCC 7644. Six L. lactis subsp. lactis, representing 5% of
the strain tested, were found to retain antimicrobial activity,
showing around the well a measurable clear zone with mean
values ranging from 2.3 to 3.7mm (Table 2,c o n t r o l ) .T h e
substances produced by these strains were neither hydrogen
peroxide nor organic acid since the inhibitory activity was
not aﬀected by catalase and was maintained in neutralized
supernatants.
Several studies have demonstrated the antagonistic activ-
ity of autochthonous cultures isolated from dairy products
against L. monocytogenes [27–29] .T h eo c c u r r e n c eo fb a c t e -
riocin-producing Lactococcus strains found in our study is
lower than previously reported [27, 28]. On the other hand,
the frequency of isolation of bacteriocin-producing strains
is variable and could be attributed to diﬀerences such as the
origin of the strains, the isolation media and technique used
to detect antibacterial activity, and the diversity of indicator
microorganisms used for initial screening.
The cell-free supernatants from the six strains producing
antimicrobial compounds were assayed for sensitivity to
proteolytic enzymes. The antimicrobial substances from all
strains were completely inactivated by treatment with pro-
nase E and proteinase K and partially eliminated with α-
chymotrypsin. However, no loss of activity was observed
when the supernatants were treated with trypsin and papain4 Journal of Biomedicine and Biotechnology
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Figure 1: Preliminary screening for antibacterial activity of Lactococcus lactis subsp.l a c t i sstrains isolated from artisanal dairy products.
Table 2: Enzyme sensitivity of the antibacterial compounds produced by the six Lactococcus lactis subsp. lactis determined by well-diﬀusion
assay. Results are expressed as mean ± standard deviation of three independent experiments.
Producer strains Control
Residual activity against L. monocytogenes ATCC 7644 after enzymes treatment∗
Pronase E Proteinase K a-Chymotrypsin Trypsin Papain
9FS16 3.7 0 0 2 3.7 3.7
16FS16 3.7 0 0 2 3.7 3.7
9/20234 2.3 0 0 0.8 2.3 2.3
6LS5 3.7 0 0 0.5 3.7 3.7
3LC39 3.0 0 0 0.5 3.0 3.0
1LC18 2.5 0 0 0.7 2.5 2.5
Lc. lactis ATCC 11454§ 2.7 0 0 1.7 2.7 2.7
∗Inhibition zone in mm.
§Nisin A-producer.
(Table 2).Thesensitivitytoproteolyticenzymesofthestrains
was similar to that observed in the nisin A-producer L. lactis
subsp. lactis ATCC 11454 used as experimental control, thus
suggesting that the inhibitory activity is related to heat-
stable proteinaceous compounds and may be due to nisin-
like molecules which many strains of L. lactis are known
to produce [29, 30]. Further studies including puriﬁcation,
molecular characterization, and sequence determination of
nisin genes are being currently carried out in our laboratory
to conﬁrm these ﬁndings.
The eﬀects of the bacteriocin-producing strains on the
growth of L. monocytogenes ATCC 7644 in skimmed milk are
presented in Figure 2.G r o w t ho fL. monocytogenes increased
from 106 CFU/mL to 108 CFU/mL within 10h in control
samples, reaching about 109 CFU/mL after 24h of incuba-
tion. When L. monocytogenes was grown in co-culture with
the bacteriocin-producing strains, diﬀerent trends in the
growth were obtained. As can be seen, the bacteriocin-pro-
ducing strains reduced L. monocytogenes population within
10h, although diﬀerences in the degree of inhibition were
observed among the strains. The L. monocytogenes counts
were reduced by approximately 4 log units compared to the
positive control and by 2 log unit compared to the initial
inoculum. The inhibition did not seem to be correlated with
the reduction in pH during the ﬁrst 10 hours of fermenta-
tion, conﬁrming that the antimicrobial activity of the strains
is not due to the production of organic acid. Our results
suggest that these Bac+ strains could be potentially applied
in cheese-manufacturing to control the growth of L. mono-
cytogenes. In a previous study, a Bac+ L. lactis strain used in
themanufactureofJbencheesewasabletoreducethegrowth
of L. monocytogenes by 2.7 log units after 30h of processing
when an initial inoculum of 107 CFU/mL was used [31].
In order for a strain to be used as bioprotective culture,
it should be carefully evaluated for the presence of virulence
factors, to determine what potential risks might be involved
in its use. The formation of biogenic amines is of concern in
terms of food safety and quality. Biogenic amines are pro-
duced by LAB during the process of fermentation of foods
and beverages by amino acid decarboxylation. Bover-Cid
and Holzapfel [24] suggested that the capability to produce
biogenic amines in a synthetic medium might be strainJournal of Biomedicine and Biotechnology 5
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Figure 2:GrowthofListeriamonocytogenesinco-culturewithLactococcuslactissubsp.lactisbacteriocin-producingstrains.Microbialcounts
werecalculatedasthenumberofcolony-formingunits(CFU)permLandreportedaslog10 CFU/mL.Dataareexpressedasmean ±standard
errors from two independent experiments each with two replicates.6 Journal of Biomedicine and Biotechnology
Table 3: Antibiotic resistance of the six bacteriocin-producing Lactococcus lactis subsp. lactis strains isolated from artisanal dairy products.
Antibiotic tested 9FS16 16FS16 9/20234 6LS5 3LC39 1LC18
Ampicillin (10μg) S S S S S S
Vancomycin (30μg) S S S S S S
Streptomycin (10μg) R R R R R R
Tetracycline (30μg) S S S S S S
Gentamicin (10μg) R R S S S S
Kanamycin (30μg) R R R R S S
Erythromycin (15μg) S S S S S S
Chloramphenicol (30μg) S S S S S S
Clindamycin (2μg) S S S S S S
Ciproﬂoxacin (5μg) S S S S S S
Cotrimoxazole (25μg) R R R R R R
dependent rather than being related to speciﬁc species. In
our screening, none of the strains tested was found to
decarboxylate lysine, histidine, ornithine, or tyrosine (data
not shown), in agreement with other ﬁndings [32, 33].
Haemolytic activity is a trait associated with virulence in
some food-associated microorganisms, such as enterococci
[34, 35] ,b u ti th a sn o tb e e nf r e q u e n t l yr e p o r t e df o rl a c t o -
cocci of dairy origin [36]. In our study no strain showed
haemolytic activity on sheep blood (data not shown).
The antimicrobial resistance of Lactococcus strains is
reported in Table 3.Withinthegroupofantimicrobialagents
that inhibit the cell wall synthesis, all strains were suscep-
tible to ampicillin and vancomycin. All strains were also
susceptible to tetracycline, erythromycin, chloramphenicol,
and clindamycin. Regarding the aminoglycosides, all strains
were resistant to streptomycin, the majority to kanamycin
and two to gentamycin. As for the antibiotics that inhibit the
nucleic acids synthesis, all strains were resistant to trimetho-
prim/sulphametoxazole and none to ciproﬂoxacin. When
multiple resistance is taken into account, two strains were
resistant to two antibiotics, two to three, and two to four.
Because of their long-time use in various food and feed
products, LAB have been given the GRAS status [37, 38];
however, several studies have recently documented the pres-
ence and expression of antibiotic resistance genes in food-
associated LAB including probiotics [39, 40], even though
this trait is not commonly found in dairy LAB species
[41]. Recently, the European Food Safety Authority (EFSA)
has introduced the Qualiﬁed Presumption of Safety (QPS)
concept, which is similar to the GRAS system in the United
States and would allow microorganisms for which there are
no special safety concerns to enter the market without ex-
tensive testing requirements [42]. The presence of acquired
antibiotic resistance is considered by EFSA an important
safety criterion for determining a strain’s QPS status [43].
In this study, all strains analysed were generally resistant to
aminoglycosides and trimethoprim/sulphametoxazole and
sensitive to other clinically important antibiotics such as
ampicillin, tetracycline, and vancomycin, in agreement with
other ﬁndings [36, 44, 45], but in contrast with some reports
where a high frequency of tetracycline resistance in L. lactis
of probiotic and dairy origin was observed [46, 47], or a
high percentage of L. lactis strains resistant to ciproﬂoxacin
found[48].Aspreviouslyreported[48],diﬀerentresultsmay
be explained by the lack of standardization in phenotypic
antibiotic resistance testing in LAB food isolates, including
diﬀerences in methods and media used.
Resistance to some antibiotics such as aminoglycosides
has been reported to be intrinsic for lactococci [44, 48, 49];
but particular attention should be paid to the presence of
transferable resistance, since strains of L. lactis have been
reported to harbor diﬀerent plasmid-encoded resistance de-
terminants [40, 46, 50].
4. Conclusions
The in situ production of bacteriocins by lactococcal strains
in dairy foods provides a very attractive alternative to the
use of puriﬁed bacteriocin, since many of them also generate
speciﬁcaromasandﬂavors,butseveralissuesincludingsafety
and adequate technological properties of the selected strains
need to be addressed.
As the L. lactis strains tested in our study originated
from artisanal goat and sheep dairy products and exhibited a
strong inhibitory activity against L. monocytogenes, they may
be useful in controlling the growth of this pathogen in dairy
fermentation. The low level of antibiotic resistance observed
in our strains could be of interest for a possible techno-
logical application since it has been demonstrated that L.
lactis isolates displaying properties of technological interest
generallyexhibitedalow-resistancephenotype(lessthantwo
antibiotics) [44].
Application of these bacteriocin-producing strains in
food system studies is necessary to determine their eﬀective-
ness. The characterization of the bacteriocins and the tech-
nological properties of the strains are currently being inves-
tigated.
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